The present work is focussed on the principles of photodynamic therapy (PDT), emphasizing
the photochemical mechanisms of reactive oxygen species formation and the consequent …

The focus of this review is to describe the state-of-art in the development of innovative drug
delivery systems for phthalocyanines as photosensitizers for photodynamic therapy (PDT) …

Photodynamic therapy (PDT) is a minimally invasive approach, in which a photosensitiser
compound is activated by exposure to visible light. The activation of the sensitiser drug …

Photodynamic therapy (PDT) is a minimally invasive approach, in which a photosensitizer
compound is activated by exposure to light. The activation of the sensitizer drug results in …

Purpose As a promising photodynamic therapy (PDT) agent, Al (III) phthalocyanine chloride
tetrasulfonic acid (AlPcS4) provides deep penetration into tissue, high quantum yields, good …

Human trichomoniasis, caused by the pathogenic parasitic protozoan Trichomonas
vaginalis, is the most common non-viral sexually transmitted disease that contributes to …

Background The application of a new generation of photosensitizers to increase the efficacy
of antifungal photodynamic therapy (aPDT) is an important aspect of PDT. Thus, this in vitro …

Tritrichomonas foetus, a parasite well known for its significance as venereally transmitted
pathogen in cattle, has recently been identified as a cause of chronic large-bowel diarrhea …

Photodynamic therapy (PDT) has been originally developed for the treatment of cancer, but
it has been successfully employed in the treatment of infectious diseases, including fungal …

Limited cellular delivery and internalization efficiency of Al (III) phthalocyanine chloride
tetrasulfonic acid (AlPcS4) induce poor penetration ability in cells and a slight photodynamic …